Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
27.63
-0.98 (-3.43%)
Mar 3, 2026, 1:00 PM EST - Market open
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $1.6 billion as of March 3, 2026. Its market cap has increased by 54.23% in one year.
Market Cap
1.60B
Enterprise Value
1.42B
1-Year Change
54.23%
Ranking
Category
Stock Price
$27.63
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $1.60B, an increase of 904.11%. That is a compound annual growth rate of 61.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 1.65B | 43.26% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | 159.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 1.76B |
| Sarepta Therapeutics | 1.76B |
| Zymeworks | 1.74B |
| Definium Therapeutics | 1.72B |
| Veradermics | 1.71B |
| Innoviva | 1.70B |
| Oruka Therapeutics | 1.67B |
| Kodiak Sciences | 1.66B |